Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Jul 1, 2023 to Jul 1, 2023
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| National Institutes of Health Niaid | BOLDER BIOTECHNOLOGY INC | Jul 1, 2023 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Premium
Clean & enrich your CRM automatically
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018
Effective Date
Sep 9, 2019
Expires
Effective: Sep 9, 2019
TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018
ActiveTO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018
Effective Date
Sep 9, 2019
Expires
Effective: Sep 9, 2019
TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018
ActiveDEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR INDIAN FLYING FOX (BAT) BIOMARKERS
Effective Date
Sep 1, 2024
Expires
Effective: Sep 1, 2024
DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR INDIAN FLYING FOX (BAT) BIOMARKERS
ActivePHASE II DEVELOPMENT OF RAPID MOLECULAR ASSAY FOR POINT OF CARE DETECTION OF TREPONEMA PALLIDUM
Effective Date
Sep 3, 2024
Expires
Effective: Sep 3, 2024
PHASE II DEVELOPMENT OF RAPID MOLECULAR ASSAY FOR POINT OF CARE DETECTION OF TREPONEMA PALLIDUM
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Premium
Get complete source documentation & analysis